13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001420995
Total reported value
$467.8M
$467.8M
10 檔
134.9%
During the Q1 2025 filing period, Trustees of Columbia University in the City of New York (CIK: 0001420995) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $467.8M across 10 reported positions.
In Q1 2025, Trustees of Columbia University in the City of New York adopted a defensive or profit-taking posture, trimming 2 positions and completely liquidating 12 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 98.27% | -1.24% | +3.50% | |
| 2 | NU | Nu Holdings Ltd. | Stock-Financials | 1.48% | — | +737.97% | |
| 3 | SRZN | Surrozen Inc | Stock-Other | 0.09% | — | — | |
| 4 | VIGL | Vigil Neuroscience Inc | Stock-Other | 0.05% | — | — | |
| 5 | QTTB | Q32 Bio Inc | Stock-Other | 0.03% | — | — | |
| 6 | ✓ | Xilio Therapeutics Inc | Stock-Other | 0.03% | — | — | |
| 7 | TNYA | Tenaya Therapeutics Inc | Stock-Other | 0.03% | — | — | |
| 8 | ✓ | Rapt Therapeutics Inc | Stock-Other | 0.01% | — | — | |
| 9 | VOR | Vor Biopharma Inc. | Stock-Other | 0.01% | — | — | |
| 10 | SRZNW | Surrozen Inc-cw25 | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Rapt Therapeutics Inc | -3.7% | — | Trim |
| 2 | VOR | Vor Biopharma Inc. | -5.1% | — | Trim |
| 3 | SPY | Ss Spdr S&p 500 ETF Trust-us | — | NEW | New buy |
| 4 | BRK-A | Berkshire Hathaway Inc-cl A | — | EXIT | Sold out |
| 5 | KYMR | Kymera Therapeutics Inc | — | EXIT | Sold out |
| 6 | NU | Nu Holdings Ltd. | — | NEW | New buy |
| 7 | SANA | Sana Biotechnology Inc | — | EXIT | Sold out |
| 8 | ASAN | Asana Inc - Cl A | — | EXIT | Sold out |
| 9 | ✓ | Evelo Biosciences Inc | — | EXIT | Sold out |
| 10 | SFIX | Stitch Fix Inc-class A | — | EXIT | Sold out |
| 11 | MSFT | Microsoft CORP | — | EXIT | Sold out |
| 12 | KLDO | Kaleido Biosciences Inc | — | EXIT | Sold out |
| 13 | ZEN1EUR | Zendesk Inc | — | EXIT | Sold out |
| 14 | PGNY | Progyny Inc | — | EXIT | Sold out |
| 15 | SRZN | Surrozen Inc | — | NEW | New buy |
| 16 | SNOW | Snowflake Inc | — | EXIT | Sold out |
| 17 | VIGL | Vigil Neuroscience Inc | — | NEW | New buy |
| 18 | BRK-B | Berkshire Hathaway Inc-cl B | — | EXIT | Sold out |
| 19 | QTTB | Q32 Bio Inc | — | NEW | New buy |
| 20 | ✓ | Xilio Therapeutics Inc | — | NEW | New buy |
| 21 | TNYA | Tenaya Therapeutics Inc | — | NEW | New buy |
| 22 | SRZNW | Surrozen Inc-cw25 | — | NEW | New buy |
According to official SEC Form 13F filings, Trustees of Columbia University in the City of New York reported a total U.S. public equity portfolio value of $467.8M across 10 disclosed positions in Q1 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including SPY, NU, SRZN) accounted for 134.9% of total reported equity market value during Q1 2025.
Top New Position Initiated
SPY
市值: $620.6M
Top Position Liquidated / Trimmed
BRK-A
前期市值: $32.7M
During Q1 2025, Trustees of Columbia University in the City of New York's top holdings by market value included SPY (98.3%)、NU (1.5%)、SRZN (0.1%). The largest single position, SPY, represented 98.3% of total portfolio value.
In Q1 2025, Trustees of Columbia University in the City of New York made 22 total portfolio adjustments, initiating 8 new buys, adding to 0 positions, trimming 2 holdings, and fully liquidating 12 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.